| [1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
| [2] |
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics.2014[J]. CA Cancer J Clin, 2014, 64(4): 25 2-71.
|
| [3] |
Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing[J]. N Engl J Med, 2012, 366(10): 883-92.
|
| [4] |
Oesper L, Satas G, Raphael BJ, et al. Quantifying tumor heterogeneity in whole-Genome and whole-exome sequencing data[J]. Bioinformatics, 2014, 30(24): 3532-40.
|
| [5] |
Kaise M, Miwa J, Tashiro J, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk[J]. J Gastroenterol, 2011, 46(6): 73 6-45.
|
| [6] |
Aikou S, Ohmoto Y, Gunji T, et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening[J]. Gastroenterology, 2011, 141(3): 837-45.
|
| [7] |
Huang Z, Zhang X, Lu H, et al. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China[J]. BMC Gastroenterol, 2014,14:74.
|
| [8] |
Casado E, Garcia VM, Sánchez JJ, et al. Upregulation of trefoil factor 3(TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target[J]. Int J Radiat Oncol Biol Phys, 2012, 84(5): 1151-8.
|
| [9] |
Li Y, Sun Z, Liu K, et al. Prognostic significance of the coexpression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients[J]. Mol Clin Oncol, 2014, 2(6): 1055-61.
|
| [10] |
Takano T, Yamada H. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma[J]. Endocr J, 20 09, 56(1): 9-16.
|
| [11] |
Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing[J]. Nat Rev Mol Cell Bio, 2003, 4(9): 721-32.
|
| [12] |
Kjellev S. The trefoil factor family-small peptides with multiple functionalities[J]. Cell Mol Life Sci, 2009, 66(8): 1350-69.
|
| [13] |
Madsen J, Nielsen O, Tornøe I, et al. Tissue localization of human trefoil factors 1, 2, and 3[J]. J Histochem Cytochem, 2007, 55(5): 50 5-13.
|
| [14] |
May PE. The potential of trefoil proteins as biomarkers in human cancer[J]. Biomarkers Med, 2012, 6(3): 301-4.
|
| [15] |
Kaise M, Miwa J, Fujimoto A, et al. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker[J]. Gastric Cancer, 2013, 16(3): 329-37.
|
| [16] |
Bignotti E, Ravaggi A, Tassi RA, et al. Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas[J]. Br J Cancer, 2008, 99(5): 76 8-73.
|
| [17] |
Qu Y, Yang Y, Ma D, et al. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer[J]. Oncol Rep, 2012, 27(4): 1277-83.
|
| [18] |
Astor BC, Köttgen A, Hwang SJ, et al. Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study[J]. Am J Nephrol, 2011, 34(4): 291-7.
|
| [19] |
Du TY, Luo HM, Qin HC, et al. Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease[J]. PLoS One, 2013, 8(11): e80271.
|
| [20] |
Ding A, Zhao W, Shi X, et al. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer[J]. PLoS One, 2013, 8(12): e82136.
|
| [21] |
Morito K, Nakamura J, Kitajima Y, et al. The value of trefoil factor 3 expression in predicting the long?term outcome and early recurrence of colorectal cancer[J]. Int J Oncol, 2015, 46(2): 563-8.
|
| [22] |
Meng JR, Tang HZ, Zhou KZ, et al. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer[J]. Clin Exp Med, 2013, 13(4): 297-303.
|
| [23] |
Im S, Yoo C, Jung JH, et al. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis[J]. Int J Med Sci, 20 13, 10(2): 133-40.
|
| [24] |
Xiao L, Liu YP, Xiao CX, et al. Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers[J]. BMC Clin Pathol, 2014, 14: 26.
|
| [25] |
Mhawech-Fauceglia P, Yan L, Liu S, et al. ER+/PR+/TFF3+/ IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases[J]. Histopathology, 2013, 62(7): 976-85.
|
| [26] |
Foukakis T, Gusnanto A, Au AY, et al. A PCR-based expression signature of malignancy in follicular thyroid tumors[J]. Endocr Relat Cancer, 2007, 14(2): 381-91.
|
| [27] |
Krause K, Eszlinger M, Gimm O, et al. TFF3-based candidate gene discrimination of benign and malignant thyoid tumors in a region with borderline iodine deficiency[J]. J Clin Endocrinol Metab, 2008, 93(4): 1390-3.
|
| [28] |
Yamada H, Takano T, Kihara M, et al. Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases[J]. Endocr J, 2012, 59(7): 621-30.
|
| [29] |
Takano T. Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing[J]. Rinsho Byori, 2012, 60(2): 132-8.
|
| [30] |
Ahmed AR, Griffiths AB, Tilby MT, et al. TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease[J]. Am J Pathol, 2012, 180(3): 904-16.
|
| [31] |
Pandey V, Wu ZS, Zhang M, et al. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma[J]. Breast Cancer Res, 2014, 16(5): 429.
|
| [32] |
May FEB, Griffin SM, Westly BR, et al. The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the coexpression of these proteins is deregulated in gastric cancer[J]. Int J Biochem Cell Biol, 2009, 41(3): 632-40.
|
| [33] |
Yu H, He Y, Zhang X, et al. The rat IgGFcγBP and Muc2 C-terminal domains and TFF3 in two intestinal mucus layers bind together by covalent interaction[J]. PLoS One, 2011, 6(5): e20334.
|
| [34] |
Yang XN, Lu YP, Liu JJ, et al. Piezo1 is as a novel trefoil factor family 1 binding protein that promotes gastric cancer cell mobility in vitro[J]. Dig Dis Sci, 2014, 59(7): 1428-35.
|
| [35] |
Dubeykovskaya Z, Dubeykovskiy A, Solal-Cohen J, et al. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines[J]. J Biol Chem, 2009, 284(6): 36 50-62.
|
| [36] |
Zhang Y, Yu G, Wang Y, et al. Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2[J]. Cell Mol Life Sci, 2011, 68(22): 3771-80.
|
| [37] |
Storesund T, Schenck K, Osmundsen H, et al. Signal transduction and gene transcription induced by TFF3 in oral keratinocytes[J]. Eur J Oral Sci, 2009, 117(5): 511-7.
|
| [38] |
Guleng B, Han J, Yang JQ, et al. TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells[J]. Mol Biol Rep, 2012, 39(4): 4127-34.
|
| [39] |
Lin N, Xu LF, Sun M. The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3K/Akt dependent mechanism[J]. Biochem Biophys Res Commun, 2013, 440(1): 143-9.
|
| [40] |
Zheng Q, Gao J, Li H, et al. Trefoil factor 3 peptide regulates migration via a Twist-dependent pathway in gastric cell[J]. Biochem Biophys Res Commun, 2013, 438(1): 6-12.
|
| [41] |
Mhawech-Fauceglia P, Wang D, Samrao D, et al. Trefoil factor family 3(TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma[J]. Gynecol Oncol, 20 13, 130(1): 174-80.
|
下载:
